Aigen Investment Management, LP Exelixis, Inc. Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$19.25 - $24.13 $389,831 - $488,656
20,251 New
20,251 $485,000
Q1 2023

May 15, 2023
BUY
$16.3 - $19.41 $393,433 - $468,499
24,137 New
24,137 $468,000
Q3 2022

Nov 09, 2022
BUY
$15.68 - $22.27 $259,629 - $368,746
16,558 New
16,558 $260,000
Q4 2020

Feb 12, 2021
SELL
$18.39 - $24.8 $214,004 - $288,597
-11,637 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$20.67 - $26.94 $240,536 - $313,500
11,637 New
11,637 $285,000

Others Institutions Holding EXEL

# of Institutions
501
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email